Pharma Investments

top of page

WSE_logo_artwork-rgb_outline_dark green.png

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

3 days ago1 min read

Worthy Endeavor: SciSparc’s AI Pivot Sparks Trading Frenzy

Worthy Endeavor: SciSparc’s AI Pivot Sparks Trading Frenzy

Worthy Endeavor: SciSparc’s AI Pivot Sparks Trading Frenzy

Worthy Endeavors

6 days ago1 min read

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

Worthy Endeavors

6 days ago2 min read

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

Oct 131 min read

Reported $3 Billion BD Expansion Puts Cash Flow in Focus

Reported $3 Billion BD Expansion Puts Cash Flow in Focus

Reported $3 Billion BD Expansion Puts Cash Flow in Focus

Oct 71 min read

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavors

Oct 71 min read

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Pharma Investments

Oct 61 min read

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Oct 51 min read

Novo Nordisk’s $23 Billion Growth Plan Fails to Reassure Investors

Novo Nordisk’s $23 Billion Growth Plan Fails to Reassure Investors

Novo Nordisk’s $23 Billion Growth Plan Fails to Reassure Investors

Pharma Investments

Sep 212 min read

Bank of America Is Spending 13% of Its Healthcare Budget on GLP-1 Drugs

Bank of America Is Spending 13% of Its Healthcare Budget on GLP-1 Drugs

Bank of America Is Spending 13% of Its Healthcare Budget on GLP-1 Drugs

Sep 182 min read

MapLight’s Schizophrenia Drug Worked, but Can It Compete?

MapLight’s Schizophrenia Drug Worked, but Can It Compete?

MapLight’s Schizophrenia Drug Worked, but Can It Compete?

Sep 162 min read

Eli Lilly's Latest Acquisition Isn't Just About One Drug It's About the Future of Mental Health

Eli Lilly's Latest Acquisition Isn't Just About One Drug It's About the Future of Mental Health

Eli Lilly's Latest Acquisition Isn't Just About One Drug It's About the Future of Mental Health

Sep 142 min read

Merck Isn't Reinventing Cholesterol Drugs It's Reinventing How Patients Use Them

Merck Isn't Reinventing Cholesterol Drugs It's Reinventing How Patients Use Them

Merck Isn't Reinventing Cholesterol Drugs It's Reinventing How Patients Use Them

Sep 142 min read

Moderna Just Took mRNA Beyond Covid

Moderna Just Took mRNA Beyond Covid

Moderna Just Took mRNA Beyond Covid

Aug 102 min read

Trump’s Drug Pricing Push Could Put Smaller Pharma Firms Under Pressure

Trump’s Drug Pricing Push Could Put Smaller Pharma Firms Under Pressure

Trump’s Drug Pricing Push Could Put Smaller Pharma Firms Under Pressure

Aug 101 min read

2

bottom of page